|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:NRF1-IDH2 (FusionGDB2 ID:59894) |
Fusion Gene Summary for NRF1-IDH2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: NRF1-IDH2 | Fusion gene ID: 59894 | Hgene | Tgene | Gene symbol | NRF1 | IDH2 | Gene ID | 4899 | 3418 |
Gene name | nuclear respiratory factor 1 | isocitrate dehydrogenase (NADP(+)) 2 | |
Synonyms | ALPHA-PAL | D2HGA2|ICD-M|IDH|IDHM|IDP|IDPM|mNADP-IDH | |
Cytomap | 7q32.2 | 15q26.1 | |
Type of gene | protein-coding | protein-coding | |
Description | nuclear respiratory factor 1alpha palindromic-binding protein | isocitrate dehydrogenase [NADP], mitochondrialNADP(+)-specific ICDHisocitrate dehydrogenase (NADP(+)) 2, mitochondrialisocitrate dehydrogenase 2 (NADP+), mitochondrialoxalosuccinate decarboxylase | |
Modification date | 20200329 | 20200313 | |
UniProtAcc | . | P48735 | |
Ensembl transtripts involved in fusion gene | ENST00000393232, ENST00000353868, ENST00000539636, ENST00000311967, ENST00000223190, ENST00000393230, ENST00000393231, ENST00000477428, | ENST00000330062, ENST00000539790, ENST00000559482, ENST00000540499, | |
Fusion gene scores | * DoF score | 14 X 9 X 8=1008 | 6 X 6 X 5=180 |
# samples | 16 | 8 | |
** MAII score | log2(16/1008*10)=-2.65535182861255 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/180*10)=-1.16992500144231 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: NRF1 [Title/Abstract] AND IDH2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | NRF1(129297414)-IDH2(90634876), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene breakpoints across NRF1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across IDH2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-BR-A4QI-01A | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
Top |
Fusion Gene ORF analysis for NRF1-IDH2 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000393232 | ENST00000330062 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
5CDS-intron | ENST00000393232 | ENST00000539790 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
5CDS-intron | ENST00000393232 | ENST00000559482 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
5CDS-5UTR | ENST00000393232 | ENST00000540499 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
In-frame | ENST00000353868 | ENST00000330062 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
5CDS-intron | ENST00000353868 | ENST00000539790 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
5CDS-intron | ENST00000353868 | ENST00000559482 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
5CDS-5UTR | ENST00000353868 | ENST00000540499 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
5UTR-3CDS | ENST00000539636 | ENST00000330062 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
5UTR-intron | ENST00000539636 | ENST00000539790 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
5UTR-intron | ENST00000539636 | ENST00000559482 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
5UTR-5UTR | ENST00000539636 | ENST00000540499 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
In-frame | ENST00000311967 | ENST00000330062 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
5CDS-intron | ENST00000311967 | ENST00000539790 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
5CDS-intron | ENST00000311967 | ENST00000559482 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
5CDS-5UTR | ENST00000311967 | ENST00000540499 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
In-frame | ENST00000223190 | ENST00000330062 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
5CDS-intron | ENST00000223190 | ENST00000539790 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
5CDS-intron | ENST00000223190 | ENST00000559482 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
5CDS-5UTR | ENST00000223190 | ENST00000540499 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
In-frame | ENST00000393230 | ENST00000330062 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
5CDS-intron | ENST00000393230 | ENST00000539790 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
5CDS-intron | ENST00000393230 | ENST00000559482 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
5CDS-5UTR | ENST00000393230 | ENST00000540499 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
In-frame | ENST00000393231 | ENST00000330062 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
5CDS-intron | ENST00000393231 | ENST00000539790 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
5CDS-intron | ENST00000393231 | ENST00000559482 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
5CDS-5UTR | ENST00000393231 | ENST00000540499 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
intron-3CDS | ENST00000477428 | ENST00000330062 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
intron-intron | ENST00000477428 | ENST00000539790 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
intron-intron | ENST00000477428 | ENST00000559482 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
intron-5UTR | ENST00000477428 | ENST00000540499 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000393232 | NRF1 | chr7 | 129297414 | + | ENST00000330062 | IDH2 | chr15 | 90634876 | - | 2805 | 340 | 117 | 1583 | 488 |
ENST00000353868 | NRF1 | chr7 | 129297414 | + | ENST00000330062 | IDH2 | chr15 | 90634876 | - | 2805 | 340 | 117 | 1583 | 488 |
ENST00000311967 | NRF1 | chr7 | 129297414 | + | ENST00000330062 | IDH2 | chr15 | 90634876 | - | 2766 | 301 | 78 | 1544 | 488 |
ENST00000223190 | NRF1 | chr7 | 129297414 | + | ENST00000330062 | IDH2 | chr15 | 90634876 | - | 2766 | 301 | 78 | 1544 | 488 |
ENST00000393230 | NRF1 | chr7 | 129297414 | + | ENST00000330062 | IDH2 | chr15 | 90634876 | - | 2798 | 333 | 110 | 1576 | 488 |
ENST00000393231 | NRF1 | chr7 | 129297414 | + | ENST00000330062 | IDH2 | chr15 | 90634876 | - | 2689 | 224 | 1 | 1467 | 488 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000393232 | ENST00000330062 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - | 0.003730453 | 0.9962696 |
ENST00000353868 | ENST00000330062 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - | 0.003730453 | 0.9962696 |
ENST00000311967 | ENST00000330062 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - | 0.003435225 | 0.9965648 |
ENST00000223190 | ENST00000330062 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - | 0.003435225 | 0.9965648 |
ENST00000393230 | ENST00000330062 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - | 0.002589415 | 0.9974106 |
ENST00000393231 | ENST00000330062 | NRF1 | chr7 | 129297414 | + | IDH2 | chr15 | 90634876 | - | 0.003110657 | 0.9968893 |
Top |
Fusion Genomic Features for NRF1-IDH2 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for NRF1-IDH2 |
Go to FGviewer for the breakpoints of chr7:129297414-chr15:90634876 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | IDH2 |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Plays a role in intermediary metabolism and energy production. It may tightly associate or interact with the pyruvate dehydrogenase complex. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | NRF1 | chr7:129297414 | chr15:90634876 | ENST00000223190 | + | 2 | 11 | 41_66 | 74.33333333333333 | 504.0 | Compositional bias | Note=Asp/Glu-rich (acidic) |
Hgene | NRF1 | chr7:129297414 | chr15:90634876 | ENST00000353868 | + | 2 | 10 | 41_66 | 74.33333333333333 | 438.0 | Compositional bias | Note=Asp/Glu-rich (acidic) |
Hgene | NRF1 | chr7:129297414 | chr15:90634876 | ENST00000393230 | + | 2 | 11 | 41_66 | 74.33333333333333 | 504.0 | Compositional bias | Note=Asp/Glu-rich (acidic) |
Hgene | NRF1 | chr7:129297414 | chr15:90634876 | ENST00000393232 | + | 2 | 11 | 41_66 | 74.33333333333333 | 504.0 | Compositional bias | Note=Asp/Glu-rich (acidic) |
Tgene | IDH2 | chr7:129297414 | chr15:90634876 | ENST00000330062 | 0 | 11 | 115_117 | 38.333333333333336 | 453.0 | Nucleotide binding | NADP | |
Tgene | IDH2 | chr7:129297414 | chr15:90634876 | ENST00000330062 | 0 | 11 | 349_354 | 38.333333333333336 | 453.0 | Nucleotide binding | NADP | |
Tgene | IDH2 | chr7:129297414 | chr15:90634876 | ENST00000330062 | 0 | 11 | 134_140 | 38.333333333333336 | 453.0 | Region | Substrate binding |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | NRF1 | chr7:129297414 | chr15:90634876 | ENST00000223190 | + | 2 | 11 | 80_86 | 74.33333333333333 | 504.0 | Compositional bias | Note=Poly-Ala |
Hgene | NRF1 | chr7:129297414 | chr15:90634876 | ENST00000353868 | + | 2 | 10 | 80_86 | 74.33333333333333 | 438.0 | Compositional bias | Note=Poly-Ala |
Hgene | NRF1 | chr7:129297414 | chr15:90634876 | ENST00000393230 | + | 2 | 11 | 80_86 | 74.33333333333333 | 504.0 | Compositional bias | Note=Poly-Ala |
Hgene | NRF1 | chr7:129297414 | chr15:90634876 | ENST00000393232 | + | 2 | 11 | 80_86 | 74.33333333333333 | 504.0 | Compositional bias | Note=Poly-Ala |
Hgene | NRF1 | chr7:129297414 | chr15:90634876 | ENST00000223190 | + | 2 | 11 | 109_305 | 74.33333333333333 | 504.0 | DNA binding | . |
Hgene | NRF1 | chr7:129297414 | chr15:90634876 | ENST00000353868 | + | 2 | 10 | 109_305 | 74.33333333333333 | 438.0 | DNA binding | . |
Hgene | NRF1 | chr7:129297414 | chr15:90634876 | ENST00000393230 | + | 2 | 11 | 109_305 | 74.33333333333333 | 504.0 | DNA binding | . |
Hgene | NRF1 | chr7:129297414 | chr15:90634876 | ENST00000393232 | + | 2 | 11 | 109_305 | 74.33333333333333 | 504.0 | DNA binding | . |
Hgene | NRF1 | chr7:129297414 | chr15:90634876 | ENST00000223190 | + | 2 | 11 | 88_116 | 74.33333333333333 | 504.0 | Motif | Note=Nuclear localization signal |
Hgene | NRF1 | chr7:129297414 | chr15:90634876 | ENST00000353868 | + | 2 | 10 | 88_116 | 74.33333333333333 | 438.0 | Motif | Note=Nuclear localization signal |
Hgene | NRF1 | chr7:129297414 | chr15:90634876 | ENST00000393230 | + | 2 | 11 | 88_116 | 74.33333333333333 | 504.0 | Motif | Note=Nuclear localization signal |
Hgene | NRF1 | chr7:129297414 | chr15:90634876 | ENST00000393232 | + | 2 | 11 | 88_116 | 74.33333333333333 | 504.0 | Motif | Note=Nuclear localization signal |
Hgene | NRF1 | chr7:129297414 | chr15:90634876 | ENST00000223190 | + | 2 | 11 | 1_78 | 74.33333333333333 | 504.0 | Region | Note=Dimerization |
Hgene | NRF1 | chr7:129297414 | chr15:90634876 | ENST00000223190 | + | 2 | 11 | 301_476 | 74.33333333333333 | 504.0 | Region | Note=Required for transcriptional activation |
Hgene | NRF1 | chr7:129297414 | chr15:90634876 | ENST00000353868 | + | 2 | 10 | 1_78 | 74.33333333333333 | 438.0 | Region | Note=Dimerization |
Hgene | NRF1 | chr7:129297414 | chr15:90634876 | ENST00000353868 | + | 2 | 10 | 301_476 | 74.33333333333333 | 438.0 | Region | Note=Required for transcriptional activation |
Hgene | NRF1 | chr7:129297414 | chr15:90634876 | ENST00000393230 | + | 2 | 11 | 1_78 | 74.33333333333333 | 504.0 | Region | Note=Dimerization |
Hgene | NRF1 | chr7:129297414 | chr15:90634876 | ENST00000393230 | + | 2 | 11 | 301_476 | 74.33333333333333 | 504.0 | Region | Note=Required for transcriptional activation |
Hgene | NRF1 | chr7:129297414 | chr15:90634876 | ENST00000393232 | + | 2 | 11 | 1_78 | 74.33333333333333 | 504.0 | Region | Note=Dimerization |
Hgene | NRF1 | chr7:129297414 | chr15:90634876 | ENST00000393232 | + | 2 | 11 | 301_476 | 74.33333333333333 | 504.0 | Region | Note=Required for transcriptional activation |
Top |
Fusion Gene Sequence for NRF1-IDH2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000393232_ENST00000330062_TCGA-BR-A4QI-01A_NRF1_chr7_129297414_+_IDH2_chr15_90634876_length(transcript)=2805nt_BP=340nt GGCGGCAGAAGCGGCAGCGCTCGCCATTGCCGCTGGTGGCAGGAGGCTGCGAGGAGCCGGCGCGGTCGCAGTCTCCACGGCGCAGGCCCA CGGTAGCGCAGCCGCTCTGAGAACTTCATGGAGGAACACGGAGTGACCCAAACCGAACATATGGCTACCATAGAAGCACATGCAGTGGCC CAGCAAGTGCAGCAGGTCCATGTGGCTACTTACACCGAGCATAGTATGCTGAGTGCTGATGAAGACTCGCCTTCTTCTCCCGAGGACACC TCTTACGATGACTCAGATATACTCAACTCCACAGCAGCTGATGAGGTGACAGCTCATCTGGCAGCTGCAGATGCCGACAAAAGGATCAAG GTGGCGAAGCCCGTGGTGGAGATGGATGGTGATGAGATGACCCGTATTATCTGGCAGTTCATCAAGGAGAAGCTCATCCTGCCCCACGTG GACATCCAGCTAAAGTATTTTGACCTCGGGCTCCCAAACCGTGACCAGACTGATGACCAGGTCACCATTGACTCTGCACTGGCCACCCAG AAGTACAGTGTGGCTGTCAAGTGTGCCACCATCACCCCTGATGAGGCCCGTGTGGAAGAGTTCAAGCTGAAGAAGATGTGGAAAAGTCCC AATGGAACTATCCGGAACATCCTGGGGGGGACTGTCTTCCGGGAGCCCATCATCTGCAAAAACATCCCACGCCTAGTCCCTGGCTGGACC AAGCCCATCACCATTGGCAGGCACGCCCATGGCGACCAGTACAAGGCCACAGACTTTGTGGCAGACCGGGCCGGCACTTTCAAAATGGTC TTCACCCCAAAAGATGGCAGTGGTGTCAAGGAGTGGGAAGTGTACAACTTCCCCGCAGGCGGCGTGGGCATGGGCATGTACAACACCGAC GAGTCCATCTCAGGTTTTGCGCACAGCTGCTTCCAGTATGCCATCCAGAAGAAATGGCCGCTGTACATGAGCACCAAGAACACCATACTG AAAGCCTACGATGGGCGTTTCAAGGACATCTTCCAGGAGATCTTTGACAAGCACTATAAGACCGACTTCGACAAGAATAAGATCTGGTAT GAGCACCGGCTCATTGATGACATGGTGGCTCAGGTCCTCAAGTCTTCGGGTGGCTTTGTGTGGGCCTGCAAGAACTATGACGGAGATGTG CAGTCAGACATCCTGGCCCAGGGCTTTGGCTCCCTTGGCCTGATGACGTCCGTCCTGGTCTGCCCTGATGGGAAGACGATTGAGGCTGAG GCCGCTCATGGGACCGTCACCCGCCACTATCGGGAGCACCAGAAGGGCCGGCCCACCAGCACCAACCCCATCGCCAGCATCTTTGCCTGG ACACGTGGCCTGGAGCACCGGGGGAAGCTGGATGGGAACCAAGACCTCATCAGGTTTGCCCAGATGCTGGAGAAGGTGTGCGTGGAGACG GTGGAGAGTGGAGCCATGACCAAGGACCTGGCGGGCTGCATTCACGGCCTCAGCAATGTGAAGCTGAACGAGCACTTCCTGAACACCACG GACTTCCTCGACACCATCAAGAGCAACCTGGACAGAGCCCTGGGCAGGCAGTAGGGGGAGGCGCCACCCATGGCTGCAGTGGAGGGGCCA GGGCTGAGCCGGCGGGTCCTCCTGAGCGCGGCAGAGGGTGAGCCTCACAGCCCCTCTCTGGAGGCCTTTCTAGGGGATGTTTTTTTATAA GCCAGATGTTTTTAAAAGCATATGTGTGTTTCCCCTCATGGTGACGTGAGGCAGGAGCAGTGCGTTTTACCTCAGCCAGTCAGTATGTTT TGCATACTGTAATTTATATTGCCCTTGGAACACATGGTGCCATATTTAGCTACTAAAAAGCTCTTCACAAAATTGTCTGCTGTGTTTGTC CCTGAGGGGAGGAGGTAGTGGGACCCTGAGGCAGAGGCCCTGCTAGAGCTGGCAGGTTCCCCTGGGGCAGACCAGAGCACCTCAGGAAGG GGCTGCCACGGCAGGGAAGGGACCAGGCAGCCCTGGGAGCCCGCATTCCACAGGGGCCCACTGCGGAGTTCTCGGACACTCAGGGCACAG GCCTGTGGGTTCCCTGGAATTTTCTAGCATGATCCAGTTTCTGTGTCCAGTTCTCCATTCTGAGAGTCAATCAGTTCCTGATAGGTTGTC ATTGATTTTTTTCTTCGTTGGTTTTAACCTTCTAAACATCTCCAGGCCACTTTCTTAGCCTTTTTCTAGGTACTAAAAAGAGGTCCTACC CACACCTGCCTCACACTTCTCCTTTCCAAGGCTGCCTGAGTTTGGAGGGGCTTGGGTGTGTGTGAACAAGGGCCCTGCATTGTCTAGGCC TGCAGTTCCCAGGCTTGGGTTCACTTTCACCATGCATTGGCAAAACTAGAAAAGTAAGCTTGTGACAAATTGTTCTCGGCCGGGCACAGT GGCGCACGCCTATAATCCCTGTACTTTGGGAGGCTGAGGTGGGTGGATCACTTGAGGCCAGGAGTTCGAGACCAGCCTGGCCAACATGGT GAAACCCCATCTCTACTCAAAATACAAAAATTAGCCAGGCGTGGTGATGCGCACCTGCAGTCCCAGCTACTCGGGAGGCTGAGGCAGGAA AATGGCTTGAACCTGGGAGGCAGAGGTTGCAGTGAGCCGAGACTGCACCACTGCACTCCAGCCTGGGTGACAGAGCAAGACTCTGTCTCA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAATTGCTCTATGCAAGTTTTTTAGCCCCATGTAAAAAGGAAAAATAAAAGTTGCTCTAAAGC >In-frame_ENST00000393232_ENST00000330062_TCGA-BR-A4QI-01A_NRF1_chr7_129297414_+_IDH2_chr15_90634876_length(amino acids)=488AA_start in transcript=117_stop in transcript=1583 MEEHGVTQTEHMATIEAHAVAQQVQQVHVATYTEHSMLSADEDSPSSPEDTSYDDSDILNSTAADEVTAHLAAADADKRIKVAKPVVEMD GDEMTRIIWQFIKEKLILPHVDIQLKYFDLGLPNRDQTDDQVTIDSALATQKYSVAVKCATITPDEARVEEFKLKKMWKSPNGTIRNILG GTVFREPIICKNIPRLVPGWTKPITIGRHAHGDQYKATDFVADRAGTFKMVFTPKDGSGVKEWEVYNFPAGGVGMGMYNTDESISGFAHS CFQYAIQKKWPLYMSTKNTILKAYDGRFKDIFQEIFDKHYKTDFDKNKIWYEHRLIDDMVAQVLKSSGGFVWACKNYDGDVQSDILAQGF GSLGLMTSVLVCPDGKTIEAEAAHGTVTRHYREHQKGRPTSTNPIASIFAWTRGLEHRGKLDGNQDLIRFAQMLEKVCVETVESGAMTKD -------------------------------------------------------------- >In-frame_ENST00000353868_ENST00000330062_TCGA-BR-A4QI-01A_NRF1_chr7_129297414_+_IDH2_chr15_90634876_length(transcript)=2805nt_BP=340nt GGCGGCAGAAGCGGCAGCGCTCGCCATTGCCGCTGGTGGCAGGAGGCTGCGAGGAGCCGGCGCGGTCGCAGTCTCCACGGCGCAGGCCCA CGGTAGCGCAGCCGCTCTGAGAACTTCATGGAGGAACACGGAGTGACCCAAACCGAACATATGGCTACCATAGAAGCACATGCAGTGGCC CAGCAAGTGCAGCAGGTCCATGTGGCTACTTACACCGAGCATAGTATGCTGAGTGCTGATGAAGACTCGCCTTCTTCTCCCGAGGACACC TCTTACGATGACTCAGATATACTCAACTCCACAGCAGCTGATGAGGTGACAGCTCATCTGGCAGCTGCAGATGCCGACAAAAGGATCAAG GTGGCGAAGCCCGTGGTGGAGATGGATGGTGATGAGATGACCCGTATTATCTGGCAGTTCATCAAGGAGAAGCTCATCCTGCCCCACGTG GACATCCAGCTAAAGTATTTTGACCTCGGGCTCCCAAACCGTGACCAGACTGATGACCAGGTCACCATTGACTCTGCACTGGCCACCCAG AAGTACAGTGTGGCTGTCAAGTGTGCCACCATCACCCCTGATGAGGCCCGTGTGGAAGAGTTCAAGCTGAAGAAGATGTGGAAAAGTCCC AATGGAACTATCCGGAACATCCTGGGGGGGACTGTCTTCCGGGAGCCCATCATCTGCAAAAACATCCCACGCCTAGTCCCTGGCTGGACC AAGCCCATCACCATTGGCAGGCACGCCCATGGCGACCAGTACAAGGCCACAGACTTTGTGGCAGACCGGGCCGGCACTTTCAAAATGGTC TTCACCCCAAAAGATGGCAGTGGTGTCAAGGAGTGGGAAGTGTACAACTTCCCCGCAGGCGGCGTGGGCATGGGCATGTACAACACCGAC GAGTCCATCTCAGGTTTTGCGCACAGCTGCTTCCAGTATGCCATCCAGAAGAAATGGCCGCTGTACATGAGCACCAAGAACACCATACTG AAAGCCTACGATGGGCGTTTCAAGGACATCTTCCAGGAGATCTTTGACAAGCACTATAAGACCGACTTCGACAAGAATAAGATCTGGTAT GAGCACCGGCTCATTGATGACATGGTGGCTCAGGTCCTCAAGTCTTCGGGTGGCTTTGTGTGGGCCTGCAAGAACTATGACGGAGATGTG CAGTCAGACATCCTGGCCCAGGGCTTTGGCTCCCTTGGCCTGATGACGTCCGTCCTGGTCTGCCCTGATGGGAAGACGATTGAGGCTGAG GCCGCTCATGGGACCGTCACCCGCCACTATCGGGAGCACCAGAAGGGCCGGCCCACCAGCACCAACCCCATCGCCAGCATCTTTGCCTGG ACACGTGGCCTGGAGCACCGGGGGAAGCTGGATGGGAACCAAGACCTCATCAGGTTTGCCCAGATGCTGGAGAAGGTGTGCGTGGAGACG GTGGAGAGTGGAGCCATGACCAAGGACCTGGCGGGCTGCATTCACGGCCTCAGCAATGTGAAGCTGAACGAGCACTTCCTGAACACCACG GACTTCCTCGACACCATCAAGAGCAACCTGGACAGAGCCCTGGGCAGGCAGTAGGGGGAGGCGCCACCCATGGCTGCAGTGGAGGGGCCA GGGCTGAGCCGGCGGGTCCTCCTGAGCGCGGCAGAGGGTGAGCCTCACAGCCCCTCTCTGGAGGCCTTTCTAGGGGATGTTTTTTTATAA GCCAGATGTTTTTAAAAGCATATGTGTGTTTCCCCTCATGGTGACGTGAGGCAGGAGCAGTGCGTTTTACCTCAGCCAGTCAGTATGTTT TGCATACTGTAATTTATATTGCCCTTGGAACACATGGTGCCATATTTAGCTACTAAAAAGCTCTTCACAAAATTGTCTGCTGTGTTTGTC CCTGAGGGGAGGAGGTAGTGGGACCCTGAGGCAGAGGCCCTGCTAGAGCTGGCAGGTTCCCCTGGGGCAGACCAGAGCACCTCAGGAAGG GGCTGCCACGGCAGGGAAGGGACCAGGCAGCCCTGGGAGCCCGCATTCCACAGGGGCCCACTGCGGAGTTCTCGGACACTCAGGGCACAG GCCTGTGGGTTCCCTGGAATTTTCTAGCATGATCCAGTTTCTGTGTCCAGTTCTCCATTCTGAGAGTCAATCAGTTCCTGATAGGTTGTC ATTGATTTTTTTCTTCGTTGGTTTTAACCTTCTAAACATCTCCAGGCCACTTTCTTAGCCTTTTTCTAGGTACTAAAAAGAGGTCCTACC CACACCTGCCTCACACTTCTCCTTTCCAAGGCTGCCTGAGTTTGGAGGGGCTTGGGTGTGTGTGAACAAGGGCCCTGCATTGTCTAGGCC TGCAGTTCCCAGGCTTGGGTTCACTTTCACCATGCATTGGCAAAACTAGAAAAGTAAGCTTGTGACAAATTGTTCTCGGCCGGGCACAGT GGCGCACGCCTATAATCCCTGTACTTTGGGAGGCTGAGGTGGGTGGATCACTTGAGGCCAGGAGTTCGAGACCAGCCTGGCCAACATGGT GAAACCCCATCTCTACTCAAAATACAAAAATTAGCCAGGCGTGGTGATGCGCACCTGCAGTCCCAGCTACTCGGGAGGCTGAGGCAGGAA AATGGCTTGAACCTGGGAGGCAGAGGTTGCAGTGAGCCGAGACTGCACCACTGCACTCCAGCCTGGGTGACAGAGCAAGACTCTGTCTCA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAATTGCTCTATGCAAGTTTTTTAGCCCCATGTAAAAAGGAAAAATAAAAGTTGCTCTAAAGC >In-frame_ENST00000353868_ENST00000330062_TCGA-BR-A4QI-01A_NRF1_chr7_129297414_+_IDH2_chr15_90634876_length(amino acids)=488AA_start in transcript=117_stop in transcript=1583 MEEHGVTQTEHMATIEAHAVAQQVQQVHVATYTEHSMLSADEDSPSSPEDTSYDDSDILNSTAADEVTAHLAAADADKRIKVAKPVVEMD GDEMTRIIWQFIKEKLILPHVDIQLKYFDLGLPNRDQTDDQVTIDSALATQKYSVAVKCATITPDEARVEEFKLKKMWKSPNGTIRNILG GTVFREPIICKNIPRLVPGWTKPITIGRHAHGDQYKATDFVADRAGTFKMVFTPKDGSGVKEWEVYNFPAGGVGMGMYNTDESISGFAHS CFQYAIQKKWPLYMSTKNTILKAYDGRFKDIFQEIFDKHYKTDFDKNKIWYEHRLIDDMVAQVLKSSGGFVWACKNYDGDVQSDILAQGF GSLGLMTSVLVCPDGKTIEAEAAHGTVTRHYREHQKGRPTSTNPIASIFAWTRGLEHRGKLDGNQDLIRFAQMLEKVCVETVESGAMTKD -------------------------------------------------------------- >In-frame_ENST00000311967_ENST00000330062_TCGA-BR-A4QI-01A_NRF1_chr7_129297414_+_IDH2_chr15_90634876_length(transcript)=2766nt_BP=301nt GAGGCTGCGAGGAGCCGGCGCGGTCGCAGTCTCCACGGCGCAGGCCCACGGTAGCGCAGCCGCTCTGAGTAGAACTTCATGGAGGAACAC GGAGTGACCCAAACCGAACATATGGCTACCATAGAAGCACATGCAGTGGCCCAGCAAGTGCAGCAGGTCCATGTGGCTACTTACACCGAG CATAGTATGCTGAGTGCTGATGAAGACTCGCCTTCTTCTCCCGAGGACACCTCTTACGATGACTCAGATATACTCAACTCCACAGCAGCT GATGAGGTGACAGCTCATCTGGCAGCTGCAGATGCCGACAAAAGGATCAAGGTGGCGAAGCCCGTGGTGGAGATGGATGGTGATGAGATG ACCCGTATTATCTGGCAGTTCATCAAGGAGAAGCTCATCCTGCCCCACGTGGACATCCAGCTAAAGTATTTTGACCTCGGGCTCCCAAAC CGTGACCAGACTGATGACCAGGTCACCATTGACTCTGCACTGGCCACCCAGAAGTACAGTGTGGCTGTCAAGTGTGCCACCATCACCCCT GATGAGGCCCGTGTGGAAGAGTTCAAGCTGAAGAAGATGTGGAAAAGTCCCAATGGAACTATCCGGAACATCCTGGGGGGGACTGTCTTC CGGGAGCCCATCATCTGCAAAAACATCCCACGCCTAGTCCCTGGCTGGACCAAGCCCATCACCATTGGCAGGCACGCCCATGGCGACCAG TACAAGGCCACAGACTTTGTGGCAGACCGGGCCGGCACTTTCAAAATGGTCTTCACCCCAAAAGATGGCAGTGGTGTCAAGGAGTGGGAA GTGTACAACTTCCCCGCAGGCGGCGTGGGCATGGGCATGTACAACACCGACGAGTCCATCTCAGGTTTTGCGCACAGCTGCTTCCAGTAT GCCATCCAGAAGAAATGGCCGCTGTACATGAGCACCAAGAACACCATACTGAAAGCCTACGATGGGCGTTTCAAGGACATCTTCCAGGAG ATCTTTGACAAGCACTATAAGACCGACTTCGACAAGAATAAGATCTGGTATGAGCACCGGCTCATTGATGACATGGTGGCTCAGGTCCTC AAGTCTTCGGGTGGCTTTGTGTGGGCCTGCAAGAACTATGACGGAGATGTGCAGTCAGACATCCTGGCCCAGGGCTTTGGCTCCCTTGGC CTGATGACGTCCGTCCTGGTCTGCCCTGATGGGAAGACGATTGAGGCTGAGGCCGCTCATGGGACCGTCACCCGCCACTATCGGGAGCAC CAGAAGGGCCGGCCCACCAGCACCAACCCCATCGCCAGCATCTTTGCCTGGACACGTGGCCTGGAGCACCGGGGGAAGCTGGATGGGAAC CAAGACCTCATCAGGTTTGCCCAGATGCTGGAGAAGGTGTGCGTGGAGACGGTGGAGAGTGGAGCCATGACCAAGGACCTGGCGGGCTGC ATTCACGGCCTCAGCAATGTGAAGCTGAACGAGCACTTCCTGAACACCACGGACTTCCTCGACACCATCAAGAGCAACCTGGACAGAGCC CTGGGCAGGCAGTAGGGGGAGGCGCCACCCATGGCTGCAGTGGAGGGGCCAGGGCTGAGCCGGCGGGTCCTCCTGAGCGCGGCAGAGGGT GAGCCTCACAGCCCCTCTCTGGAGGCCTTTCTAGGGGATGTTTTTTTATAAGCCAGATGTTTTTAAAAGCATATGTGTGTTTCCCCTCAT GGTGACGTGAGGCAGGAGCAGTGCGTTTTACCTCAGCCAGTCAGTATGTTTTGCATACTGTAATTTATATTGCCCTTGGAACACATGGTG CCATATTTAGCTACTAAAAAGCTCTTCACAAAATTGTCTGCTGTGTTTGTCCCTGAGGGGAGGAGGTAGTGGGACCCTGAGGCAGAGGCC CTGCTAGAGCTGGCAGGTTCCCCTGGGGCAGACCAGAGCACCTCAGGAAGGGGCTGCCACGGCAGGGAAGGGACCAGGCAGCCCTGGGAG CCCGCATTCCACAGGGGCCCACTGCGGAGTTCTCGGACACTCAGGGCACAGGCCTGTGGGTTCCCTGGAATTTTCTAGCATGATCCAGTT TCTGTGTCCAGTTCTCCATTCTGAGAGTCAATCAGTTCCTGATAGGTTGTCATTGATTTTTTTCTTCGTTGGTTTTAACCTTCTAAACAT CTCCAGGCCACTTTCTTAGCCTTTTTCTAGGTACTAAAAAGAGGTCCTACCCACACCTGCCTCACACTTCTCCTTTCCAAGGCTGCCTGA GTTTGGAGGGGCTTGGGTGTGTGTGAACAAGGGCCCTGCATTGTCTAGGCCTGCAGTTCCCAGGCTTGGGTTCACTTTCACCATGCATTG GCAAAACTAGAAAAGTAAGCTTGTGACAAATTGTTCTCGGCCGGGCACAGTGGCGCACGCCTATAATCCCTGTACTTTGGGAGGCTGAGG TGGGTGGATCACTTGAGGCCAGGAGTTCGAGACCAGCCTGGCCAACATGGTGAAACCCCATCTCTACTCAAAATACAAAAATTAGCCAGG CGTGGTGATGCGCACCTGCAGTCCCAGCTACTCGGGAGGCTGAGGCAGGAAAATGGCTTGAACCTGGGAGGCAGAGGTTGCAGTGAGCCG AGACTGCACCACTGCACTCCAGCCTGGGTGACAGAGCAAGACTCTGTCTCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAATTGCTCTAT >In-frame_ENST00000311967_ENST00000330062_TCGA-BR-A4QI-01A_NRF1_chr7_129297414_+_IDH2_chr15_90634876_length(amino acids)=488AA_start in transcript=78_stop in transcript=1544 MEEHGVTQTEHMATIEAHAVAQQVQQVHVATYTEHSMLSADEDSPSSPEDTSYDDSDILNSTAADEVTAHLAAADADKRIKVAKPVVEMD GDEMTRIIWQFIKEKLILPHVDIQLKYFDLGLPNRDQTDDQVTIDSALATQKYSVAVKCATITPDEARVEEFKLKKMWKSPNGTIRNILG GTVFREPIICKNIPRLVPGWTKPITIGRHAHGDQYKATDFVADRAGTFKMVFTPKDGSGVKEWEVYNFPAGGVGMGMYNTDESISGFAHS CFQYAIQKKWPLYMSTKNTILKAYDGRFKDIFQEIFDKHYKTDFDKNKIWYEHRLIDDMVAQVLKSSGGFVWACKNYDGDVQSDILAQGF GSLGLMTSVLVCPDGKTIEAEAAHGTVTRHYREHQKGRPTSTNPIASIFAWTRGLEHRGKLDGNQDLIRFAQMLEKVCVETVESGAMTKD -------------------------------------------------------------- >In-frame_ENST00000223190_ENST00000330062_TCGA-BR-A4QI-01A_NRF1_chr7_129297414_+_IDH2_chr15_90634876_length(transcript)=2766nt_BP=301nt GAGGCTGCGAGGAGCCGGCGCGGTCGCAGTCTCCACGGCGCAGGCCCACGGTAGCGCAGCCGCTCTGAGTAGAACTTCATGGAGGAACAC GGAGTGACCCAAACCGAACATATGGCTACCATAGAAGCACATGCAGTGGCCCAGCAAGTGCAGCAGGTCCATGTGGCTACTTACACCGAG CATAGTATGCTGAGTGCTGATGAAGACTCGCCTTCTTCTCCCGAGGACACCTCTTACGATGACTCAGATATACTCAACTCCACAGCAGCT GATGAGGTGACAGCTCATCTGGCAGCTGCAGATGCCGACAAAAGGATCAAGGTGGCGAAGCCCGTGGTGGAGATGGATGGTGATGAGATG ACCCGTATTATCTGGCAGTTCATCAAGGAGAAGCTCATCCTGCCCCACGTGGACATCCAGCTAAAGTATTTTGACCTCGGGCTCCCAAAC CGTGACCAGACTGATGACCAGGTCACCATTGACTCTGCACTGGCCACCCAGAAGTACAGTGTGGCTGTCAAGTGTGCCACCATCACCCCT GATGAGGCCCGTGTGGAAGAGTTCAAGCTGAAGAAGATGTGGAAAAGTCCCAATGGAACTATCCGGAACATCCTGGGGGGGACTGTCTTC CGGGAGCCCATCATCTGCAAAAACATCCCACGCCTAGTCCCTGGCTGGACCAAGCCCATCACCATTGGCAGGCACGCCCATGGCGACCAG TACAAGGCCACAGACTTTGTGGCAGACCGGGCCGGCACTTTCAAAATGGTCTTCACCCCAAAAGATGGCAGTGGTGTCAAGGAGTGGGAA GTGTACAACTTCCCCGCAGGCGGCGTGGGCATGGGCATGTACAACACCGACGAGTCCATCTCAGGTTTTGCGCACAGCTGCTTCCAGTAT GCCATCCAGAAGAAATGGCCGCTGTACATGAGCACCAAGAACACCATACTGAAAGCCTACGATGGGCGTTTCAAGGACATCTTCCAGGAG ATCTTTGACAAGCACTATAAGACCGACTTCGACAAGAATAAGATCTGGTATGAGCACCGGCTCATTGATGACATGGTGGCTCAGGTCCTC AAGTCTTCGGGTGGCTTTGTGTGGGCCTGCAAGAACTATGACGGAGATGTGCAGTCAGACATCCTGGCCCAGGGCTTTGGCTCCCTTGGC CTGATGACGTCCGTCCTGGTCTGCCCTGATGGGAAGACGATTGAGGCTGAGGCCGCTCATGGGACCGTCACCCGCCACTATCGGGAGCAC CAGAAGGGCCGGCCCACCAGCACCAACCCCATCGCCAGCATCTTTGCCTGGACACGTGGCCTGGAGCACCGGGGGAAGCTGGATGGGAAC CAAGACCTCATCAGGTTTGCCCAGATGCTGGAGAAGGTGTGCGTGGAGACGGTGGAGAGTGGAGCCATGACCAAGGACCTGGCGGGCTGC ATTCACGGCCTCAGCAATGTGAAGCTGAACGAGCACTTCCTGAACACCACGGACTTCCTCGACACCATCAAGAGCAACCTGGACAGAGCC CTGGGCAGGCAGTAGGGGGAGGCGCCACCCATGGCTGCAGTGGAGGGGCCAGGGCTGAGCCGGCGGGTCCTCCTGAGCGCGGCAGAGGGT GAGCCTCACAGCCCCTCTCTGGAGGCCTTTCTAGGGGATGTTTTTTTATAAGCCAGATGTTTTTAAAAGCATATGTGTGTTTCCCCTCAT GGTGACGTGAGGCAGGAGCAGTGCGTTTTACCTCAGCCAGTCAGTATGTTTTGCATACTGTAATTTATATTGCCCTTGGAACACATGGTG CCATATTTAGCTACTAAAAAGCTCTTCACAAAATTGTCTGCTGTGTTTGTCCCTGAGGGGAGGAGGTAGTGGGACCCTGAGGCAGAGGCC CTGCTAGAGCTGGCAGGTTCCCCTGGGGCAGACCAGAGCACCTCAGGAAGGGGCTGCCACGGCAGGGAAGGGACCAGGCAGCCCTGGGAG CCCGCATTCCACAGGGGCCCACTGCGGAGTTCTCGGACACTCAGGGCACAGGCCTGTGGGTTCCCTGGAATTTTCTAGCATGATCCAGTT TCTGTGTCCAGTTCTCCATTCTGAGAGTCAATCAGTTCCTGATAGGTTGTCATTGATTTTTTTCTTCGTTGGTTTTAACCTTCTAAACAT CTCCAGGCCACTTTCTTAGCCTTTTTCTAGGTACTAAAAAGAGGTCCTACCCACACCTGCCTCACACTTCTCCTTTCCAAGGCTGCCTGA GTTTGGAGGGGCTTGGGTGTGTGTGAACAAGGGCCCTGCATTGTCTAGGCCTGCAGTTCCCAGGCTTGGGTTCACTTTCACCATGCATTG GCAAAACTAGAAAAGTAAGCTTGTGACAAATTGTTCTCGGCCGGGCACAGTGGCGCACGCCTATAATCCCTGTACTTTGGGAGGCTGAGG TGGGTGGATCACTTGAGGCCAGGAGTTCGAGACCAGCCTGGCCAACATGGTGAAACCCCATCTCTACTCAAAATACAAAAATTAGCCAGG CGTGGTGATGCGCACCTGCAGTCCCAGCTACTCGGGAGGCTGAGGCAGGAAAATGGCTTGAACCTGGGAGGCAGAGGTTGCAGTGAGCCG AGACTGCACCACTGCACTCCAGCCTGGGTGACAGAGCAAGACTCTGTCTCAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAATTGCTCTAT >In-frame_ENST00000223190_ENST00000330062_TCGA-BR-A4QI-01A_NRF1_chr7_129297414_+_IDH2_chr15_90634876_length(amino acids)=488AA_start in transcript=78_stop in transcript=1544 MEEHGVTQTEHMATIEAHAVAQQVQQVHVATYTEHSMLSADEDSPSSPEDTSYDDSDILNSTAADEVTAHLAAADADKRIKVAKPVVEMD GDEMTRIIWQFIKEKLILPHVDIQLKYFDLGLPNRDQTDDQVTIDSALATQKYSVAVKCATITPDEARVEEFKLKKMWKSPNGTIRNILG GTVFREPIICKNIPRLVPGWTKPITIGRHAHGDQYKATDFVADRAGTFKMVFTPKDGSGVKEWEVYNFPAGGVGMGMYNTDESISGFAHS CFQYAIQKKWPLYMSTKNTILKAYDGRFKDIFQEIFDKHYKTDFDKNKIWYEHRLIDDMVAQVLKSSGGFVWACKNYDGDVQSDILAQGF GSLGLMTSVLVCPDGKTIEAEAAHGTVTRHYREHQKGRPTSTNPIASIFAWTRGLEHRGKLDGNQDLIRFAQMLEKVCVETVESGAMTKD -------------------------------------------------------------- >In-frame_ENST00000393230_ENST00000330062_TCGA-BR-A4QI-01A_NRF1_chr7_129297414_+_IDH2_chr15_90634876_length(transcript)=2798nt_BP=333nt CCCCTTTCAGTTCCTGGTCCAGAACTTTACACAGAAAAGGTGCTCAAAGGATATTTGTTTAATGAATGTGGTATGCTGACATTTAAACAG GACAAAACTTGTAGAACTTCATGGAGGAACACGGAGTGACCCAAACCGAACATATGGCTACCATAGAAGCACATGCAGTGGCCCAGCAAG TGCAGCAGGTCCATGTGGCTACTTACACCGAGCATAGTATGCTGAGTGCTGATGAAGACTCGCCTTCTTCTCCCGAGGACACCTCTTACG ATGACTCAGATATACTCAACTCCACAGCAGCTGATGAGGTGACAGCTCATCTGGCAGCTGCAGATGCCGACAAAAGGATCAAGGTGGCGA AGCCCGTGGTGGAGATGGATGGTGATGAGATGACCCGTATTATCTGGCAGTTCATCAAGGAGAAGCTCATCCTGCCCCACGTGGACATCC AGCTAAAGTATTTTGACCTCGGGCTCCCAAACCGTGACCAGACTGATGACCAGGTCACCATTGACTCTGCACTGGCCACCCAGAAGTACA GTGTGGCTGTCAAGTGTGCCACCATCACCCCTGATGAGGCCCGTGTGGAAGAGTTCAAGCTGAAGAAGATGTGGAAAAGTCCCAATGGAA CTATCCGGAACATCCTGGGGGGGACTGTCTTCCGGGAGCCCATCATCTGCAAAAACATCCCACGCCTAGTCCCTGGCTGGACCAAGCCCA TCACCATTGGCAGGCACGCCCATGGCGACCAGTACAAGGCCACAGACTTTGTGGCAGACCGGGCCGGCACTTTCAAAATGGTCTTCACCC CAAAAGATGGCAGTGGTGTCAAGGAGTGGGAAGTGTACAACTTCCCCGCAGGCGGCGTGGGCATGGGCATGTACAACACCGACGAGTCCA TCTCAGGTTTTGCGCACAGCTGCTTCCAGTATGCCATCCAGAAGAAATGGCCGCTGTACATGAGCACCAAGAACACCATACTGAAAGCCT ACGATGGGCGTTTCAAGGACATCTTCCAGGAGATCTTTGACAAGCACTATAAGACCGACTTCGACAAGAATAAGATCTGGTATGAGCACC GGCTCATTGATGACATGGTGGCTCAGGTCCTCAAGTCTTCGGGTGGCTTTGTGTGGGCCTGCAAGAACTATGACGGAGATGTGCAGTCAG ACATCCTGGCCCAGGGCTTTGGCTCCCTTGGCCTGATGACGTCCGTCCTGGTCTGCCCTGATGGGAAGACGATTGAGGCTGAGGCCGCTC ATGGGACCGTCACCCGCCACTATCGGGAGCACCAGAAGGGCCGGCCCACCAGCACCAACCCCATCGCCAGCATCTTTGCCTGGACACGTG GCCTGGAGCACCGGGGGAAGCTGGATGGGAACCAAGACCTCATCAGGTTTGCCCAGATGCTGGAGAAGGTGTGCGTGGAGACGGTGGAGA GTGGAGCCATGACCAAGGACCTGGCGGGCTGCATTCACGGCCTCAGCAATGTGAAGCTGAACGAGCACTTCCTGAACACCACGGACTTCC TCGACACCATCAAGAGCAACCTGGACAGAGCCCTGGGCAGGCAGTAGGGGGAGGCGCCACCCATGGCTGCAGTGGAGGGGCCAGGGCTGA GCCGGCGGGTCCTCCTGAGCGCGGCAGAGGGTGAGCCTCACAGCCCCTCTCTGGAGGCCTTTCTAGGGGATGTTTTTTTATAAGCCAGAT GTTTTTAAAAGCATATGTGTGTTTCCCCTCATGGTGACGTGAGGCAGGAGCAGTGCGTTTTACCTCAGCCAGTCAGTATGTTTTGCATAC TGTAATTTATATTGCCCTTGGAACACATGGTGCCATATTTAGCTACTAAAAAGCTCTTCACAAAATTGTCTGCTGTGTTTGTCCCTGAGG GGAGGAGGTAGTGGGACCCTGAGGCAGAGGCCCTGCTAGAGCTGGCAGGTTCCCCTGGGGCAGACCAGAGCACCTCAGGAAGGGGCTGCC ACGGCAGGGAAGGGACCAGGCAGCCCTGGGAGCCCGCATTCCACAGGGGCCCACTGCGGAGTTCTCGGACACTCAGGGCACAGGCCTGTG GGTTCCCTGGAATTTTCTAGCATGATCCAGTTTCTGTGTCCAGTTCTCCATTCTGAGAGTCAATCAGTTCCTGATAGGTTGTCATTGATT TTTTTCTTCGTTGGTTTTAACCTTCTAAACATCTCCAGGCCACTTTCTTAGCCTTTTTCTAGGTACTAAAAAGAGGTCCTACCCACACCT GCCTCACACTTCTCCTTTCCAAGGCTGCCTGAGTTTGGAGGGGCTTGGGTGTGTGTGAACAAGGGCCCTGCATTGTCTAGGCCTGCAGTT CCCAGGCTTGGGTTCACTTTCACCATGCATTGGCAAAACTAGAAAAGTAAGCTTGTGACAAATTGTTCTCGGCCGGGCACAGTGGCGCAC GCCTATAATCCCTGTACTTTGGGAGGCTGAGGTGGGTGGATCACTTGAGGCCAGGAGTTCGAGACCAGCCTGGCCAACATGGTGAAACCC CATCTCTACTCAAAATACAAAAATTAGCCAGGCGTGGTGATGCGCACCTGCAGTCCCAGCTACTCGGGAGGCTGAGGCAGGAAAATGGCT TGAACCTGGGAGGCAGAGGTTGCAGTGAGCCGAGACTGCACCACTGCACTCCAGCCTGGGTGACAGAGCAAGACTCTGTCTCAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAATTGCTCTATGCAAGTTTTTTAGCCCCATGTAAAAAGGAAAAATAAAAGTTGCTCTAAAGCTACATAT >In-frame_ENST00000393230_ENST00000330062_TCGA-BR-A4QI-01A_NRF1_chr7_129297414_+_IDH2_chr15_90634876_length(amino acids)=488AA_start in transcript=110_stop in transcript=1576 MEEHGVTQTEHMATIEAHAVAQQVQQVHVATYTEHSMLSADEDSPSSPEDTSYDDSDILNSTAADEVTAHLAAADADKRIKVAKPVVEMD GDEMTRIIWQFIKEKLILPHVDIQLKYFDLGLPNRDQTDDQVTIDSALATQKYSVAVKCATITPDEARVEEFKLKKMWKSPNGTIRNILG GTVFREPIICKNIPRLVPGWTKPITIGRHAHGDQYKATDFVADRAGTFKMVFTPKDGSGVKEWEVYNFPAGGVGMGMYNTDESISGFAHS CFQYAIQKKWPLYMSTKNTILKAYDGRFKDIFQEIFDKHYKTDFDKNKIWYEHRLIDDMVAQVLKSSGGFVWACKNYDGDVQSDILAQGF GSLGLMTSVLVCPDGKTIEAEAAHGTVTRHYREHQKGRPTSTNPIASIFAWTRGLEHRGKLDGNQDLIRFAQMLEKVCVETVESGAMTKD -------------------------------------------------------------- >In-frame_ENST00000393231_ENST00000330062_TCGA-BR-A4QI-01A_NRF1_chr7_129297414_+_IDH2_chr15_90634876_length(transcript)=2689nt_BP=224nt CATGGAGGAACACGGAGTGACCCAAACCGAACATATGGCTACCATAGAAGCACATGCAGTGGCCCAGCAAGTGCAGCAGGTCCATGTGGC TACTTACACCGAGCATAGTATGCTGAGTGCTGATGAAGACTCGCCTTCTTCTCCCGAGGACACCTCTTACGATGACTCAGATATACTCAA CTCCACAGCAGCTGATGAGGTGACAGCTCATCTGGCAGCTGCAGATGCCGACAAAAGGATCAAGGTGGCGAAGCCCGTGGTGGAGATGGA TGGTGATGAGATGACCCGTATTATCTGGCAGTTCATCAAGGAGAAGCTCATCCTGCCCCACGTGGACATCCAGCTAAAGTATTTTGACCT CGGGCTCCCAAACCGTGACCAGACTGATGACCAGGTCACCATTGACTCTGCACTGGCCACCCAGAAGTACAGTGTGGCTGTCAAGTGTGC CACCATCACCCCTGATGAGGCCCGTGTGGAAGAGTTCAAGCTGAAGAAGATGTGGAAAAGTCCCAATGGAACTATCCGGAACATCCTGGG GGGGACTGTCTTCCGGGAGCCCATCATCTGCAAAAACATCCCACGCCTAGTCCCTGGCTGGACCAAGCCCATCACCATTGGCAGGCACGC CCATGGCGACCAGTACAAGGCCACAGACTTTGTGGCAGACCGGGCCGGCACTTTCAAAATGGTCTTCACCCCAAAAGATGGCAGTGGTGT CAAGGAGTGGGAAGTGTACAACTTCCCCGCAGGCGGCGTGGGCATGGGCATGTACAACACCGACGAGTCCATCTCAGGTTTTGCGCACAG CTGCTTCCAGTATGCCATCCAGAAGAAATGGCCGCTGTACATGAGCACCAAGAACACCATACTGAAAGCCTACGATGGGCGTTTCAAGGA CATCTTCCAGGAGATCTTTGACAAGCACTATAAGACCGACTTCGACAAGAATAAGATCTGGTATGAGCACCGGCTCATTGATGACATGGT GGCTCAGGTCCTCAAGTCTTCGGGTGGCTTTGTGTGGGCCTGCAAGAACTATGACGGAGATGTGCAGTCAGACATCCTGGCCCAGGGCTT TGGCTCCCTTGGCCTGATGACGTCCGTCCTGGTCTGCCCTGATGGGAAGACGATTGAGGCTGAGGCCGCTCATGGGACCGTCACCCGCCA CTATCGGGAGCACCAGAAGGGCCGGCCCACCAGCACCAACCCCATCGCCAGCATCTTTGCCTGGACACGTGGCCTGGAGCACCGGGGGAA GCTGGATGGGAACCAAGACCTCATCAGGTTTGCCCAGATGCTGGAGAAGGTGTGCGTGGAGACGGTGGAGAGTGGAGCCATGACCAAGGA CCTGGCGGGCTGCATTCACGGCCTCAGCAATGTGAAGCTGAACGAGCACTTCCTGAACACCACGGACTTCCTCGACACCATCAAGAGCAA CCTGGACAGAGCCCTGGGCAGGCAGTAGGGGGAGGCGCCACCCATGGCTGCAGTGGAGGGGCCAGGGCTGAGCCGGCGGGTCCTCCTGAG CGCGGCAGAGGGTGAGCCTCACAGCCCCTCTCTGGAGGCCTTTCTAGGGGATGTTTTTTTATAAGCCAGATGTTTTTAAAAGCATATGTG TGTTTCCCCTCATGGTGACGTGAGGCAGGAGCAGTGCGTTTTACCTCAGCCAGTCAGTATGTTTTGCATACTGTAATTTATATTGCCCTT GGAACACATGGTGCCATATTTAGCTACTAAAAAGCTCTTCACAAAATTGTCTGCTGTGTTTGTCCCTGAGGGGAGGAGGTAGTGGGACCC TGAGGCAGAGGCCCTGCTAGAGCTGGCAGGTTCCCCTGGGGCAGACCAGAGCACCTCAGGAAGGGGCTGCCACGGCAGGGAAGGGACCAG GCAGCCCTGGGAGCCCGCATTCCACAGGGGCCCACTGCGGAGTTCTCGGACACTCAGGGCACAGGCCTGTGGGTTCCCTGGAATTTTCTA GCATGATCCAGTTTCTGTGTCCAGTTCTCCATTCTGAGAGTCAATCAGTTCCTGATAGGTTGTCATTGATTTTTTTCTTCGTTGGTTTTA ACCTTCTAAACATCTCCAGGCCACTTTCTTAGCCTTTTTCTAGGTACTAAAAAGAGGTCCTACCCACACCTGCCTCACACTTCTCCTTTC CAAGGCTGCCTGAGTTTGGAGGGGCTTGGGTGTGTGTGAACAAGGGCCCTGCATTGTCTAGGCCTGCAGTTCCCAGGCTTGGGTTCACTT TCACCATGCATTGGCAAAACTAGAAAAGTAAGCTTGTGACAAATTGTTCTCGGCCGGGCACAGTGGCGCACGCCTATAATCCCTGTACTT TGGGAGGCTGAGGTGGGTGGATCACTTGAGGCCAGGAGTTCGAGACCAGCCTGGCCAACATGGTGAAACCCCATCTCTACTCAAAATACA AAAATTAGCCAGGCGTGGTGATGCGCACCTGCAGTCCCAGCTACTCGGGAGGCTGAGGCAGGAAAATGGCTTGAACCTGGGAGGCAGAGG TTGCAGTGAGCCGAGACTGCACCACTGCACTCCAGCCTGGGTGACAGAGCAAGACTCTGTCTCAAAAAAAAAAAAAAAAAAAAAAAAAAA >In-frame_ENST00000393231_ENST00000330062_TCGA-BR-A4QI-01A_NRF1_chr7_129297414_+_IDH2_chr15_90634876_length(amino acids)=488AA_start in transcript=1_stop in transcript=1467 MEEHGVTQTEHMATIEAHAVAQQVQQVHVATYTEHSMLSADEDSPSSPEDTSYDDSDILNSTAADEVTAHLAAADADKRIKVAKPVVEMD GDEMTRIIWQFIKEKLILPHVDIQLKYFDLGLPNRDQTDDQVTIDSALATQKYSVAVKCATITPDEARVEEFKLKKMWKSPNGTIRNILG GTVFREPIICKNIPRLVPGWTKPITIGRHAHGDQYKATDFVADRAGTFKMVFTPKDGSGVKEWEVYNFPAGGVGMGMYNTDESISGFAHS CFQYAIQKKWPLYMSTKNTILKAYDGRFKDIFQEIFDKHYKTDFDKNKIWYEHRLIDDMVAQVLKSSGGFVWACKNYDGDVQSDILAQGF GSLGLMTSVLVCPDGKTIEAEAAHGTVTRHYREHQKGRPTSTNPIASIFAWTRGLEHRGKLDGNQDLIRFAQMLEKVCVETVESGAMTKD -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for NRF1-IDH2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for NRF1-IDH2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | IDH2 | P48735 | DB13874 | Enasidenib | Inhibitor | Small molecule | Approved|Investigational |
Top |
Related Diseases for NRF1-IDH2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | NRF1 | C0006079 | Bowen's Disease | 1 | CTD_human |
Tgene | IDH2 | C0028945 | oligodendroglioma | 8 | CTD_human;ORPHANET |
Tgene | IDH2 | C0334590 | Anaplastic Oligodendroglioma | 8 | CTD_human;ORPHANET |
Tgene | IDH2 | C0280793 | Mixed Oligodendroglioma-Astrocytoma | 7 | CTD_human;ORPHANET |
Tgene | IDH2 | C0334579 | Anaplastic astrocytoma | 7 | ORPHANET |
Tgene | IDH2 | C0334580 | Protoplasmic astrocytoma | 6 | ORPHANET |
Tgene | IDH2 | C0334581 | Gemistocytic astrocytoma | 6 | ORPHANET |
Tgene | IDH2 | C0334582 | Fibrillary Astrocytoma | 6 | ORPHANET |
Tgene | IDH2 | C0431108 | Anaplastic Oligoastrocytoma | 6 | ORPHANET |
Tgene | IDH2 | C3150909 | D-2-HYDROXYGLUTARIC ACIDURIA 2 | 3 | GENOMICS_ENGLAND;UNIPROT |
Tgene | IDH2 | C0013366 | Dyschondroplasias | 2 | ORPHANET |
Tgene | IDH2 | C0014084 | Enchondromatosis | 2 | CTD_human;GENOMICS_ENGLAND;ORPHANET |
Tgene | IDH2 | C0023467 | Leukemia, Myelocytic, Acute | 2 | CGI;CTD_human |
Tgene | IDH2 | C0024454 | Maffucci Syndrome | 2 | CTD_human;GENOMICS_ENGLAND;ORPHANET |
Tgene | IDH2 | C0026998 | Acute Myeloid Leukemia, M1 | 2 | CTD_human |
Tgene | IDH2 | C0079774 | Peripheral T-Cell Lymphoma | 2 | CTD_human |
Tgene | IDH2 | C0936248 | Chondroma | 2 | CTD_human |
Tgene | IDH2 | C1704356 | Enchondroma | 2 | CTD_human |
Tgene | IDH2 | C1879321 | Acute Myeloid Leukemia (AML-M2) | 2 | CTD_human |
Tgene | IDH2 | C2750850 | GLIOMA SUSCEPTIBILITY 1 | 2 | UNIPROT |
Tgene | IDH2 | C0001787 | Osteoporosis, Age-Related | 1 | CTD_human |
Tgene | IDH2 | C0007194 | Hypertrophic Cardiomyopathy | 1 | CTD_human |
Tgene | IDH2 | C0007682 | CNS disorder | 1 | CTD_human |
Tgene | IDH2 | C0018273 | Growth Disorders | 1 | CTD_human |
Tgene | IDH2 | C0018800 | Cardiomegaly | 1 | CTD_human |
Tgene | IDH2 | C0018916 | Hemangioma | 1 | CTD_human |
Tgene | IDH2 | C0020295 | Hydronephrosis | 1 | CTD_human |
Tgene | IDH2 | C0020981 | Angioimmunoblastic Lymphadenopathy | 1 | CTD_human |
Tgene | IDH2 | C0022333 | Jacksonian Seizure | 1 | CTD_human |
Tgene | IDH2 | C0023487 | Acute Promyelocytic Leukemia | 1 | CTD_human |
Tgene | IDH2 | C0027643 | Neoplasm Recurrence, Local | 1 | CTD_human |
Tgene | IDH2 | C0029408 | Degenerative polyarthritis | 1 | CTD_human |
Tgene | IDH2 | C0029456 | Osteoporosis | 1 | CTD_human |
Tgene | IDH2 | C0029459 | Osteoporosis, Senile | 1 | CTD_human |
Tgene | IDH2 | C0035078 | Kidney Failure | 1 | CTD_human |
Tgene | IDH2 | C0036572 | Seizures | 1 | CTD_human |
Tgene | IDH2 | C0086743 | Osteoarthrosis Deformans | 1 | CTD_human |
Tgene | IDH2 | C0149958 | Complex partial seizures | 1 | CTD_human |
Tgene | IDH2 | C0205788 | Histiocytoid hemangioma | 1 | CTD_human |
Tgene | IDH2 | C0205789 | Hemangioma, Intramuscular | 1 | CTD_human |
Tgene | IDH2 | C0206698 | Cholangiocarcinoma | 1 | CGI;CTD_human |
Tgene | IDH2 | C0234533 | Generalized seizures | 1 | CTD_human |
Tgene | IDH2 | C0234535 | Clonic Seizures | 1 | CTD_human |
Tgene | IDH2 | C0242698 | Ventricular Dysfunction, Left | 1 | CTD_human |
Tgene | IDH2 | C0270824 | Visual seizure | 1 | CTD_human |
Tgene | IDH2 | C0270844 | Tonic Seizures | 1 | CTD_human |
Tgene | IDH2 | C0270846 | Epileptic drop attack | 1 | CTD_human |
Tgene | IDH2 | C0279070 | Adult Oligodendroglioma | 1 | CTD_human |
Tgene | IDH2 | C0280475 | Childhood Oligodendroglioma | 1 | CTD_human |
Tgene | IDH2 | C0344461 | Oligodendroblastoma | 1 | CTD_human |
Tgene | IDH2 | C0345905 | Intrahepatic Cholangiocarcinoma | 1 | CTD_human |
Tgene | IDH2 | C0376634 | Craniofacial Abnormalities | 1 | CTD_human |
Tgene | IDH2 | C0422850 | Seizures, Somatosensory | 1 | CTD_human |
Tgene | IDH2 | C0422852 | Seizures, Auditory | 1 | CTD_human |
Tgene | IDH2 | C0422853 | Olfactory seizure | 1 | CTD_human |
Tgene | IDH2 | C0422854 | Gustatory seizure | 1 | CTD_human |
Tgene | IDH2 | C0422855 | Vertiginous seizure | 1 | CTD_human |
Tgene | IDH2 | C0494475 | Tonic - clonic seizures | 1 | CTD_human |
Tgene | IDH2 | C0677608 | Chorioangioma | 1 | CTD_human |
Tgene | IDH2 | C0751056 | Non-epileptic convulsion | 1 | CTD_human |
Tgene | IDH2 | C0751110 | Single Seizure | 1 | CTD_human |
Tgene | IDH2 | C0751123 | Atonic Absence Seizures | 1 | CTD_human |
Tgene | IDH2 | C0751395 | Mixed Oligodendroglioma-Ependymoma | 1 | CTD_human |
Tgene | IDH2 | C0751396 | Well Differentiated Oligodendroglioma | 1 | CTD_human |
Tgene | IDH2 | C0751406 | Post-Traumatic Osteoporosis | 1 | CTD_human |
Tgene | IDH2 | C0751494 | Convulsive Seizures | 1 | CTD_human |
Tgene | IDH2 | C0751495 | Seizures, Focal | 1 | CTD_human |
Tgene | IDH2 | C0751496 | Seizures, Sensory | 1 | CTD_human |
Tgene | IDH2 | C1383860 | Cardiac Hypertrophy | 1 | CTD_human |
Tgene | IDH2 | C1565489 | Renal Insufficiency | 1 | CTD_human |
Tgene | IDH2 | C1959588 | Angioma | 1 | CTD_human |
Tgene | IDH2 | C2746066 | Combined D-2- and L-2-hydroxyglutaric aciduria | 1 | CTD_human |
Tgene | IDH2 | C3152055 | D-2-HYDROXYGLUTARIC ACIDURIA 1 | 1 | ORPHANET |
Tgene | IDH2 | C3495874 | Nonepileptic Seizures | 1 | CTD_human |
Tgene | IDH2 | C3805278 | Extrahepatic Cholangiocarcinoma | 1 | CTD_human |
Tgene | IDH2 | C4048158 | Convulsions | 1 | CTD_human |
Tgene | IDH2 | C4316903 | Absence Seizures | 1 | CTD_human |
Tgene | IDH2 | C4317109 | Epileptic Seizures | 1 | CTD_human |
Tgene | IDH2 | C4317123 | Myoclonic Seizures | 1 | CTD_human |
Tgene | IDH2 | C4505436 | Generalized Absence Seizures | 1 | CTD_human |
Tgene | IDH2 | C4551472 | Hypertrophic obstructive cardiomyopathy | 1 | CTD_human |